Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|2|123-133

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.2, 2006-03, pp. : 123-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Liposomal Andrographolide to L.donovani-Infected Macrophages in Vivo

By Sinha Jayanta   Mukhopadhyay Sibabrata   Das Nirmalendu   Basu Mukul Kumar  

Drug Delivery, Vol. 7, Iss. 4, 2000-10 ,pp. : 209-213

Informa Healthcare

Access to resources Recommend Favorite

Liposomal Targeting of Angiogenic Vasculature

By  

Current Drug Delivery, Vol. 2, Iss. 4, 2005-10 ,pp. : 363-368

Bentham Science Publishers

Access to resources Recommend Favorite

hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides

By Ismair Manfred G.   Vavricka Stephan R.   Kullak-Ublick Gerd A.   Fried Michael   Mengin-Lecreulx Dominique   Girardin Stephen E.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1313-1319

NRC Research Press

Access to resources Recommend Favorite

Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy

By  

Current Bioactive Compounds, Vol. 7, Iss. 3, 2011-09 ,pp. : 180-197

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite